← All Novartis AG filings

Novartis AG Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
NVS
Novartis AG
SCHEDULE: UBS Group AG Discloses 6.37% Stake in Novartis AG with Significant Filing Delay
UBS Group AG, through its Asset Management division, has disclosed a 6.37% beneficial ownership stake in Novartis AG as of September 30, 2024, with the filing delayed due to system integration issues.